Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
Yunnan Baiyao Group Co., (000538 CH)
Watchlist
65
Analysis
Health Care
•
China
Yunnan Baiyao Group Co., Ltd. manufactures and markets traditional Chinese medicines. The Company also operates in pharmaceutical wholesale and retail trading, empty capsules manufacturing, and hotel operation.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Zhangzhou Pientzehuang Pharmaceutical Co., Ltd.
•
10 Mar 2021 09:14
Pientzehuang Pharmaceutical (600436.CH) - The Only "Double Top Secret" Traditional Chinese Medicine
The article analyzed Pien Tze Huang in terms of market potential, the scarcity, the impact of price increase, profitability comparison with...
Xinyao (Criss) Wang
Follow
624 Views
Share
bullish
•
Beijing Tong Ren Tang Chinese Medicine
•
04 Jan 2021 22:25
Beijing Tong Ren Tang Chinese Medicine: A Turnaround Worth A Look
Beijing Tong Ren Tang Chinese Medicine can be a rare turnaround case in our opinion, thanks to its wide moat and compounding capability.
Urbem Capital
Follow
718 Views
Share
bullish
•
Livzon Pharmaceutical Group In
•
02 Dec 2020 09:44
Livzon Pharmaceutical (000513.CH) - A Good Company that You Can't Afford Missing
This article analyzed Livzon's R&D highlights, main products and pipelines, financial position, and made forecast and rating for the Company.
Xinyao (Criss) Wang
Follow
644 Views
Share
bullish
•
Quantitative Analysis
•
21 Oct 2019 11:53
Shanghai/​​​Shenzhen Connect Flows: New High of Holdings by Offshore Money
In our weekly Shanghai/Shenzhen Connect Ideas series, we aim to help our investors understand the flow of northbound trades via the Shanghai and...
Ke Yan, CFA, FRM
Follow
454 Views
Share
bullish
•
Kweichow Moutai
•
16 Sep 2019 11:38
Shanghai/​​Shenzhen Connect Ideas: Pre-Mid Autumn Hard Liquor Outflows (2019-09-13)
In our weekly Shanghai/Shenzhen Connect Ideas series, we aim to help our investors understand the flow of northbound trades via the Shanghai and...
Ke Yan, CFA, FRM
Follow
488 Views
Share
First
Previous
9
10
11
12
13
Next
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4
x